Health Care/Hospital

Everest Medicines Announces China NMPA's Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients

--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patients-- SHANGHAI, Nov. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the ...

2023-11-24 12:54 3829

Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang

HANGZHOU, China, Nov. 24, 2023 /PRNewswire/ -- Broncus(2216.HK) is pleased to announce that, onNovember 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equ...

2023-11-24 09:19 4575

China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351

ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2023-11-24 08:42 4096

RewirEd Summit at COP28, the first ever global summit on education and climate, unveils agenda and speakers

DUBAI, UAE, Nov. 24, 2023 /PRNewswire/ -- RewirEd Summit, Dubai Cares' flagship platform advocating for rewired education systems as the core enabler for a sustainable future for people and planet, has unveiled the agenda for its highly anticipated 2nd edition that will take place on December 8 w...

2023-11-24 04:11 2484

Neurophet to showcase brain image analysis technology at RSNA 2023

- Introducing Alzheimer's disease related brain image analysis technology including Neurophet AQUA and Neurophet SCALE PET - Plans to launch analysis technology for infant brain image and cerebrovascular disease SEOUL, South Korea, Nov. 23, 2023 /PRNewswire/ -- Neurophet, an artificial intellig...

2023-11-23 22:00 1989

Medica 2023: Fapon Accelerates the Development of its Diagnostic Ecosystem

DUSSELDORF, Germany, Nov. 23, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, unveiled its innovative integrated solutions for diagnostics and forged strategic partnerships at the 55th International Hospital and Medical Equipment Exhibition (MEDICA 2023), held fromNovembe...

2023-11-23 17:27 2530

Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart

NANJING, China, Nov. 23, 2023 /PRNewswire/ -- On November 21, 2023, Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an innovative IL...

2023-11-23 16:04 4429

IASO Bio establishes international CAR-T diagnostic and treatment center in China to serve MM patients worldwide

NANJING, China, Nov. 23, 2023 /PRNewswire/ -- The 6th China International Import Expo (CIIE) was held inShanghai, China on November 5, 2023. Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the CIIE with FUCASO, the world's first fully-human CAR-T, and entered into a strategic pa...

2023-11-23 15:17 1926

Organic antibacterial preservative of ANDKWAN to protect both people and nature

* Evolution of Hygiene to Preserve the Earth SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- AndKwan Natural Science Inc. announced that it has succeeded in developing a new organic antibacterial preservative and an antibiotic composition containing it together with its parent company, White ...

2023-11-23 12:31 2012

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

* Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a. Clarkson Disease) and vessel-related rare disease indications * Unique Tie2-activating antibody program, PMC-403, demonstrates efficacy in improving survival and reducing vascular leak...

2023-11-23 10:31 1555

Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Accepted the New Drug Application for Taletrectinib (ROS1 Inhibitor)

ROCKVILLE, Md. and SUZHOU, China, Nov. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2023-11-23 08:00 3302

Ark Biopharmaceutical Receives IND Approval from NMPA for AK0610, a Respiratory Syncytial Virus Neutralizing Antibody

SHANGHAI, Nov. 23, 2023 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announces that it had received IND approval from National Medical Products Administration (NMPA) for a novel antibody drug AK0610. This antibody drug is bioengineered based on a neutralizing antibody origina...

2023-11-23 08:00 2434

TurtleTree obtains the world's first self-GRAS for animal-free lactoferrin, LF+™ now approved to commercialize in the U.S.

This regulatory milestone sets the stage for U.S. commercialization in Q4 2023. Using precision fermentation, TurtleTree expects profitability on LF+ in 2024 and will address global supply scarcity. SACRAMENTO, Calif. and SINGAPORE, Nov. 23, 2023 /PRNewswire/ -- TurtleTree

2023-11-23 02:14 2630

CMI Inc. and Life Molecular Imaging Announce the Reimbursement of the Amyloid-PET Diagnostic Neuraceq® (florbetaben 18F) in Japan

First Reimbursed Amyloid PET Diagnostic Tool in Japan TOKYO and BERLIN, Nov. 23, 2023 /PRNewswire/ -- CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic  Neuraceq®  (florbetaben18F injection) has been approved from the Ministry of Health, Labor, and ...

2023-11-23 01:00 1828

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with that of radiologists in detecting breast cancer SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2023-11-22 22:07 2008

United Imaging Intelligence to Unveil Cutting-edge AI Technology at RSNA

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- United Imaging Intelligence (UII), a pioneering subsidiary of United Imaging Group known for its innovative artificial intelligence (AI) applications in healthcare, is set to showcase its latest medical AI advancements at the upcoming Radiological Society o...

2023-11-22 22:00 1700

Waterdrop Inc. to Report Third Quarter 2023 Financial Results on December 7, 2023

BEIJING, Nov. 22, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform d...

2023-11-22 19:00 3542

XTrend Has Become the Silver Sponsor of Wish for the Stars Cyprus, Helping Children in Low-Resource Areas

HONG KONG, Nov. 22, 2023 /PRNewswire/ -- XTrend has been vigorously taking part in public benefit activities. In November, 2023, it became the Silver Sponsor of Wish for the Stars,Cyprus. With the guiding principle of "people-first management", it attaches great importance to social responsibilit...

2023-11-22 18:16 2379

Beyond Medical Group Achieves Coveted Recognition as One of Singapore's Top 50 Enterprises in 2023, Marking Another Milestone in Excellence

SINGAPORE, Nov. 22, 2023 /PRNewswire/ -- Beyond Wellness Group Pte Ltd ("Beyond Medical Group")- is proud to announce another remarkable milestone achieved in 2023. The Group is recognised as one ofSingapore's top 50 enterprises in Enterprise 50 Awards 2023 by The Business Times and KPMG Singapor...

2023-11-22 15:00 1555

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

* By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture to final UF/DF pool at pilot scale * This end-to-end continuous bioprocess, which is in place for WuXi Biologics global manufacturing network, is...

2023-11-22 13:21 3542
1 ... 129130131132133134135 ... 835

Week's Top Stories